Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia
Status:
Terminated
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
Pomalidomide is a newly discovered drug that may stop cancer cells from growing abnormally.
Pomalidomide may also stimulate the immune system to fight the cancer cells and possibly
improve the effectiveness of dexamethasone and rituximab to fight the Waldenstrom's
Macroglobulinemia (WM) cancer cells. This drug have been used in multiple myeloma and
information from these other research studies suggests that Pomalidomide may help to reduce
or prevent the growth of cancer cells.